HAE — HAEMONETICS CORP

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 313143 ·
Last close
$120.92
Market Cap
$5.51B
52W High
$132.00
52W Low
$51.00
ADV30
768,944
Next earnings
2027-02-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 357,759,000 220,913,000 75,120,000 46,305,000 2,410,605,000 260,712,000 1,512,108,000
Jun 2026 339,380,000 202,803,000 57,458,000 33,010,000 2,365,400,000 223,384,000 1,528,299,000
Mar 2026 346,351,000 198,212,000 52,342,000 -20,147,000 2,395,925,000 245,440,000 1,599,605,000
Dec 2025 338,967,000 202,386,000 68,112,000 44,740,000 2,490,890,000 363,367,000 1,579,439,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$344,928,000
Investing CF
$-162,600,000
Financing CF
$-218,605,000
CapEx
$-46,687,000
Dividends Paid
—
Buybacks
$-250,000,000
EPS Diluted TTM
$2.23
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$356,961,000
Inventory
$305,006,000
Receivables
$224,952,000
ST Investments
—
EBIT TTM
$176,949,000
Pretax Income TTM
$142,009,000
Interest Exp TTM
$34,940,000
Analysts
10

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,382,456,960
EBITDA
$361,214,016
Free Cash Flow
$272,701,248
Enterprise Value
$6,324,362,752
Total Cash
$260,712,000
Total Debt
$1,123,761,024
Shares Out
45,537,511
Trailing EPS
$2.26
Book Value
$19.74
ROE
11.9%
ROA
6.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 1,334,027,000 241,401,000 97,308,000 2,395,925,000 1,599,605,000 796,320,000 293,221,000
Mar 2025 1,360,824,000 201,186,000 167,679,000 2,450,948,000 1,630,112,000 820,836,000 181,725,000
Mar 2024 1,309,055,000 175,302,000 117,558,000 2,195,591,000 1,235,632,000 959,959,000 181,751,000
Mar 2023 1,168,660,000 155,651,000 115,401,000 1,934,825,000 1,116,828,000 817,997,000 273,058,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$2,365,400,000
Forward EPS
$5.78

Max Pain — expiry 2028-01-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $135.00 · spot: $122.86 · call volume: 157 · put volume: 377

Peers — same industry

TickerNameMarket CapLastDaily %
LIVN LivaNova PLC $5.06B $91.92 —
MMSI MERIT MEDICAL SYSTEMS INC $5.06B $84.49 —
MMED MiniMed Group, Inc. $5.00B $17.78 —
TFX TELEFLEX INC $6.33B $159.55 —
MSA MSA Safety Inc $6.66B $172.84 —

News headlines (Yahoo Finance, 1h cache)

Haemonetics Announces CE Mark Certification for the VASCADE MVP® XL Venous Vascular Closure System
2026-11-18 11:15 · Yahoo
HAE Q3 CY2026 deep dive: plasma growth and new product launches drive momentum
2026-11-10 12:37 · Yahoo
International Markets and Haemonetics (HAE): A Deep Dive for Investors
2026-11-09 13:15 · Yahoo
Should Raised Revenue Outlook Require Action From Haemonetics Stock Investors?
2026-11-08 02:13 · Yahoo
Haemonetics (HAE) Stock May Be 34% Undervalued On Cash Flow
2026-11-07 15:13 · Yahoo
Haemonetics Q2 Earnings Call Highlights
2026-11-07 14:15 · Yahoo
Haemonetics (HAE) Beats Q2 Expectations, Is The Stock Still Cheap?
2026-11-07 11:09 · Yahoo
Haemonetics Corp (HAE) (Q2 2027) Earnings Call Highlights: Raised Guidance and Expanded CSL ...
2026-11-06 09:12 · Yahoo
Haemonetics Corporation Q2 2027 Earnings Call Summary
2026-11-05 23:43 · Yahoo
Haemonetics (HAE) Q2 2027 Earnings Call Transcript
2026-11-05 20:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.